Financhill
Back

Dermata Therapeutics Stock Predictions

Dermata Therapeutics Stock Forecast

  • Is Dermata Therapeutics Stock Undervalued?
    The current Dermata Therapeutics [DRMA] share price is $2.25. The Score for DRMA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Dermata Therapeutics Stock Go Up Next Year?

Data Unavailable

Dermata Therapeutics Stock Rating

Data Unavailable

Dermata Therapeutics Stock Price History

Is DRMA stock going to rise?

  • The current trend is relatively stagnant and DRMA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dermatarx.com

52-Week Data

52-Week High:
17.25
52-Week Low:
1.29

Prediction Charts

Market Cap:
2.96M
Price in USD:
2.25
Volume:
580.63K
Beta:
0.79

Technical Analysis

SMA50:
2.01
SMA100:
2.83
SMA200:
5.05
52-Wk Change:
-87.07%

Stock Predictions

  • Is Dermata Therapeutics stock public?
    Yes, Dermata Therapeutics is a publicly traded company.
  • What is the Dermata Therapeutics stock quote today?
    The Dermata Therapeutics stock price is 2.25 USD today.
  • How to buy Dermata Therapeutics stock online?
    You can buy Dermata Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 1.74 1.72 1.89 1.71
Aug-30 1.76 1.74 1.80 1.71
Sep-3 1.71 1.60 1.71 1.59
Sep-4 1.61 1.51 1.61 1.48
Sep-5 1.55 1.43 1.55 1.35
Sep-6 1.43 1.58 1.64 1.43
Sep-9 1.58 1.63 1.65 1.51
Sep-10 1.63 1.61 1.63 1.53
Sep-11 1.62 1.57 1.62 1.55
Sep-12 1.60 1.45 1.60 1.42
Sep-13 1.50 1.58 1.74 1.49
Sep-16 2.38 2.32 2.49 1.86
Sep-17 2.11 2.06 2.27 1.95
Sep-18 1.93 2.25 2.38 1.93

Dermata Therapeutics Earnings

Data Unavailable

Dermata Therapeutics Forecast Revenue Growth

Data Unavailable

* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.